. 2020 Oct 14;10:593461. doi: 10.3389/fonc.2020.593461
Copyright © 2020 Parrozzani, Lombardi, Midena, Londei, Padovan, Marchione, Caccese, Midena, Zagonel and Frizziero
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 5.
ABT-414 symptoms regression. Product-Limit Survival Estimate with number of subjects at risk.